|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| 25-06-01 | Octopus Biosafety SA Auditor Raises 'Going Concern' Doubt | CI |
| 25-06-01 | Octopus Biosafety SA Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| Market Cap | 24.79M 28.66M 23.15M 21.24M 39.94M 2.73B 40.58M 272M 107M 1.37B 108M 105M 4.52B | P/E 2023 |
-1.75x | P/E 2024 | -4.2x |
|---|---|---|---|---|---|
| Enterprise Value | 25.31M 29.26M 23.64M 21.69M 40.79M 2.79B 41.44M 277M 109M 1.4B 110M 107M 4.62B | EV / Sales 2023 |
5.08x | EV / Sales 2024 | 8.46x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Bertrand Vergne
CEO | Chief Executive Officer | - | 2021-04-15 |
Dorian Pierre
CTO | Chief Tech/Sci/R&D Officer | - | 2020-12-31 |
Élodie Giroux
COO | Chief Operating Officer | - | 2020-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Bertrand Vergne
CHM | Chairman | - | 2021-04-15 |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 656K 758K 612K 562K 1.06M 72.14M 1.07M 7.18M 2.82M 36.16M 2.85M 2.78M 120M | 385K 445K 360K 330K 621K 42.37M 630K 4.22M 1.66M 21.24M 1.67M 1.64M 70.21M |
| Net income | -1.78M -2.05M -1.66M -1.52M -2.86M -196M -2.91M -19.47M -7.64M -98M -7.71M -7.55M -324M | -659K -762K -616K -565K -1.06M -72.52M -1.08M -7.22M -2.83M -36.35M -2.86M -2.8M -120M |
| Net Debt | 228K 263K 212K 195K 367K 25.03M 372K 2.49M 978K 12.55M 988K 966K 41.48M | 524K 606K 489K 449K 844K 57.65M 858K 5.74M 2.25M 28.9M 2.27M 2.22M 95.53M |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















